Delayed treatment with monoclonal antibody IN-1 1 week after stroke results in recovery of function and corticorubral plasticity in adult rats - PubMed (original) (raw)

Delayed treatment with monoclonal antibody IN-1 1 week after stroke results in recovery of function and corticorubral plasticity in adult rats

Andrew B Seymour et al. J Cereb Blood Flow Metab. 2005 Oct.

Abstract

Neuronal death due to ischemic stroke results in permanent deficits in sensory, language, and motor functions. The growth-restrictive environment of the adult central nervous system (CNS) is an obstacle to functional recovery after stroke and other CNS injuries. In this regard, Nogo-A is a potent neurite growth-inhibitory protein known to restrict neuronal plasticity in adults. Previously, we have found that treatment with monoclonal antibody (mAb) IN-1 to neutralize Nogo-A immediately after stroke enhanced motor cortico-efferent plasticity and recovery of skilled forelimb function in rats. However, immediate treatment for stroke is often not clinically feasible. Thus, the present study was undertaken to determine whether cortico-efferent plasticity and functional recovery would occur if treatment with mAb IN-1 was delayed 1 week after stroke. Adult rats were trained on a forelimb-reaching task, and the middle cerebral artery was occluded to induce focal cerebral ischemia to the forelimb sensorimotor cortex. After 1 week, animals received mAb IN-1 treatment, control antibody, or no treatment, and were tested for 9 more weeks. To assess cortico-efferent plasticity, the sensorimotor cortex opposite the stroke lesion was injected with an anterograde neuroanatomical tracer. Behavioral analysis demonstrated a recovery of skilled forelimb function, and anatomical studies revealed neuroplasticity at the level of the red nucleus in animals treated with mAb IN-1, thus demonstrating the efficacy of this treatment even if administered 1 week after stroke.

PubMed Disclaimer

Cited by

Influence of anti-Nogo-A antibody treatment on the reorganization of callosal connectivity of the premotor cortical areas following unilateral lesion of primary motor cortex (M1) in adult macaque monkeys.
Hamadjida A, Wyss AF, Mir A, Schwab ME, Belhaj-Saif A, Rouiller EM. Hamadjida A, et al. Exp Brain Res. 2012 Nov;223(3):321-40. doi: 10.1007/s00221-012-3262-x. Epub 2012 Sep 19. Exp Brain Res. 2012. PMID: 22990293 Free PMC article.
Binge ethanol prior to traumatic brain injury worsens sensorimotor functional recovery in rats.
Vaagenes IC, Tsai SY, Ton ST, Husak VA, McGuire SO, O'Brien TE, Kartje GL. Vaagenes IC, et al. PLoS One. 2015 Mar 13;10(3):e0120356. doi: 10.1371/journal.pone.0120356. eCollection 2015. PLoS One. 2015. PMID: 25768795 Free PMC article.
Indomethacin protects rats from neuronal damage induced by traumatic brain injury and suppresses hippocampal IL-1β release through the inhibition of Nogo-A expression.
Chao PK, Lu KT, Jhu JY, Wo YY, Huang TC, Ro LS, Yang YL. Chao PK, et al. J Neuroinflammation. 2012 Jun 7;9:121. doi: 10.1186/1742-2094-9-121. J Neuroinflammation. 2012. PMID: 22676811 Free PMC article.
Intrathecal treatment with anti-Nogo-A antibody improves functional recovery in adult rats after stroke.
Tsai SY, Markus TM, Andrews EM, Cheatwood JL, Emerick AJ, Mir AK, Schwab ME, Kartje GL. Tsai SY, et al. Exp Brain Res. 2007 Sep;182(2):261-6. doi: 10.1007/s00221-007-1067-0. Epub 2007 Aug 24. Exp Brain Res. 2007. PMID: 17717658
The Involvement of the Myelin-Associated Inhibitors and Their Receptors in CNS Plasticity and Injury.
Boghdadi AG, Teo L, Bourne JA. Boghdadi AG, et al. Mol Neurobiol. 2018 Mar;55(3):1831-1846. doi: 10.1007/s12035-017-0433-6. Epub 2017 Feb 22. Mol Neurobiol. 2018. PMID: 28229330 Review.

Delayed treatment with monoclonal antibody IN-1 1 week after stroke results in recovery of function and corticorubral plasticity in adult rats - PubMed (original) (raw)